Insulet
PODD
#1966
Rank
A$14.73 B
Marketcap
A$212.40
Share price
-6.16%
Change (1 day)
-56.92%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2023 (TTM): A$2.61

According to Insulet's latest financial reports the company's current EPS (TTM) is A$6.13. In 2022 the company made an earnings per share (EPS) of A$0.10 a decrease over its 2021 EPS that were of A$0.33.

EPS history for Insulet from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$2.612473.41%
2022A$0.10-69.57%
2021A$0.33109.09%
2020A$0.16-38.89%
2019A$0.26200%
2018A$0.08698-113.04%
2017A-$0.67-9.8%
2016A-$0.74-60.77%
2015A-$1.8839.78%
2014A-$1.3512.05%
2013A-$1.20-23.15%
2012A-$1.5710.2%
2011A-$1.42-36.36%
2010A-$2.23-36.63%
2009A-$3.52-29.36%
2008A-$4.99-86.74%
2007A-$37.61-64.04%
2006A-$104.60122.23%
2005A-$47.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.69 58.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$3.92-36.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.91-3.55%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$44.75 629.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A-$1.35-121.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$1.74-71.63%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$3.75-38.77%๐Ÿ‡บ๐Ÿ‡ธ USA